US › Healthcare

Armata Pharmaceuticals Inc (ARMP)

US · Healthcare · Biotechnology

$4.68-7.33%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$789,000

Revenue YoY

+60.7%

Net profit

$-115.3M

Profit YoY

-1666.1%

EPS

$-3.16

EPS estimate

$-0.38

Net margin

-14,619.3%

EPS came in at -3.16 against a street estimate of -0.38 — a miss of 731.6%.

Key statistics

Market cap

$185.4M

Forward P/E

0.0

P/B

4.06

Book value

$-8.50

EPS (TTM)

$-7.78

52-week high

$14.98

52-week low

$2.36

50-day MA

$6.31

200-day MA

$7.55

Beta

1.33

Analyst view

Analysts rate Armata Pharmaceuticals Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $17.50.

Shareholding

Insiders

68.51%

Institutions

10.79%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Armata Pharmaceuticals Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.